LJI researchers discover how loss of TET enzymes can lead to B cell lymphoma
Scientists at the La Jolla Institute for Immunology (LJI) have uncovered how loss of TET enzymes can lead to B cell lymphoma. Their research, published in Nature Immunology, could potentially open opportunities for designing drug treatment strategies to target malignant cells in many cancers. The new research was led by LJI Professor Anjana Rao, Ph.D., in the LJI Center for […]
» Read more